Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The name "Sichuang" does not appear to map cleanly to a single biotech or pharma developer. The closest identifiable healthcare-related company is Sichuang Yihui, now using the Chinese securities abbreviation Sichuang Zhilian, a China-based listed technology company focused on IoT, smart healthcare information systems, and business intelligence solutions. Historically, the company operated in smart healthcare and medical informatics, including mobile nursing and medical IoT offerings, but in 2025 it disclosed the disposal of its smart healthcare subsidiary, materially reducing its direct healthcare operating footprint. The company is therefore better characterized as a healthcare IT and IoT solutions provider than a therapeutics developer. It does not appear to have a drug pipeline, clinical-stage assets, or conventional biotech modalities such as antibodies or small molecules.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuang.